RecruitingNot Applicable

Vitamin D Analog in Vitamin D 24-hydroxylase Deficiency

France30 participantsStarted 2022-07-17

Plain-language summary

Preclinical evaluation of a vitamin D analog for the treatment of vitamin D 24-hydroxylase using fibroblast from patients with CYP24A1 mutation.

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * biallelic mutation in CYP24A1 * consent Exclusion Criteria: * none

Effects of the analog on vitamin D induced genes' expression

Timeframe: 3 years

NCT IDNCT04987073

SponsorUniversity Hospital, Caen

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-07-01